SAFETY Package

The SAFETY package is designed specifically to select for absence of clinical toxicities frequently seen for cytotoxics in the clinical practice. The package investigates toxicities that are typically not detected in conventional safety assessment strategies. The SAFETY package includes preclinical models for assessment of cardiotoxicity, gastrointestinal toxicity, alopecia, nuetropenia & peripheral neuropathy. Helps in selection of safer lead molecules or formulations at an early stage of development.

A comprehensive package for clinical toxicity screening